| Product Code: ETC12320146 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Hormone Refractory Prostate Cancer Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Hormone Refractory Prostate Cancer Market - Industry Life Cycle |
3.4 Japan Hormone Refractory Prostate Cancer Market - Porter's Five Forces |
3.5 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.6 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Hormone Refractory Prostate Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Japan |
4.2.2 Advancements in treatment options for hormone refractory prostate cancer |
4.2.3 Growing awareness and early detection of prostate cancer in the Japanese population |
4.3 Market Restraints |
4.3.1 High cost associated with advanced prostate cancer treatments |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Japan |
4.3.3 Stringent regulatory requirements for approval of new therapies in the Japanese market |
5 Japan Hormone Refractory Prostate Cancer Market Trends |
6 Japan Hormone Refractory Prostate Cancer Market, By Types |
6.1 Japan Hormone Refractory Prostate Cancer Market, By Cancer Stage |
6.1.1 Overview and Analysis |
6.1.2 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Stage, 2021 - 2031F |
6.1.3 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Castration-resistant Prostate Cancer, 2021 - 2031F |
6.1.4 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.5 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Non-metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.6 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Recurrent Prostate Cancer, 2021 - 2031F |
6.2 Japan Hormone Refractory Prostate Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Androgen Receptor Inhibitors, 2021 - 2031F |
6.2.5 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Radioisotope Therapy, 2021 - 2031F |
6.3 Japan Hormone Refractory Prostate Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Men Aged 50+, 2021 - 2031F |
6.3.3 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Urology Clinics, 2021 - 2031F |
6.3.5 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4 Japan Hormone Refractory Prostate Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Late-stage Cancer Treatment, 2021 - 2031F |
6.4.3 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Advanced Prostate Cancer Care, 2021 - 2031F |
6.4.4 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Localized Prostate Cancer, 2021 - 2031F |
6.4.5 Japan Hormone Refractory Prostate Cancer Market Revenues & Volume, By Precision Oncology, 2021 - 2031F |
7 Japan Hormone Refractory Prostate Cancer Market Import-Export Trade Statistics |
7.1 Japan Hormone Refractory Prostate Cancer Market Export to Major Countries |
7.2 Japan Hormone Refractory Prostate Cancer Market Imports from Major Countries |
8 Japan Hormone Refractory Prostate Cancer Market Key Performance Indicators |
8.1 Average age at diagnosis of hormone refractory prostate cancer in Japan |
8.2 Survival rates of patients with hormone refractory prostate cancer |
8.3 Adoption rate of new treatment modalities for hormone refractory prostate cancer |
9 Japan Hormone Refractory Prostate Cancer Market - Opportunity Assessment |
9.1 Japan Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.2 Japan Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Japan Hormone Refractory Prostate Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Japan Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Hormone Refractory Prostate Cancer Market - Competitive Landscape |
10.1 Japan Hormone Refractory Prostate Cancer Market Revenue Share, By Companies, 2024 |
10.2 Japan Hormone Refractory Prostate Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here